Clinical Trial Update: Pivotal Trial (D02) of Vagus Nerve Stimulation (VNS) for Treatment-Resistant Depression (TRD) [NA]

View source ↗

Summary

A pivotal trial evaluating vagus nerve stimulation for treatment-resistant depression has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Drugs mentioned

• Vagus nerve stimulation (VNS) device (Vagus nerve stimulation)

Snippet

Sponsor: Cyberonics, Inc. | Conditions: Major Depressive Disorder | NA | Status: COMPLETED